Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Screening|January 12, 2012
Phaedra, a protocol-driven system for analysis and validation of high-content imaging and flow cytometryFrans Cornelissen, Miroslav Cik, Emmanuel Gustin
STAR Protocols|February 20, 2026
Protocol for combining BMP, MEK, WNT inhibition and iNGN2 to enable rapid neuronal differentiation and regional patterning from hiPSCsCarina Habich, Astrid Doering, Justine D Manos, et al.
Mini Reviews in Medicinal Chemistry|October 9, 2002
Daphnane-type diterpene orthoesters and their biological activitiesWeidong He, Miroslav Cik, Giovanni Appendino, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2019
Generating Human iPSC-Derived Astrocytes with Chemically Defined Medium for In Vitro Disease ModelingKatharina Janssen, Lamiaa Bahnassawy, Claudia Kiefer, et al.
European Journal of Pharmacology|January 24, 2013
Investigation of signalling cascades induced by neurotrophic synaptolepis factor K7 reveals a critical role for novel PKCεKristof Van Kolen, Wouter Bruinzeel, Weidong He, et al.
Plos One|February 21, 2012
In vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependencyLily Alvarez-Jaimes, Steven W Sutton, Diane Nepomuceno, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2025
Using Human iPSC-Derived Astrocytes to Investigate Transcription Factor-Driven Astrocyte to Neuron TransdifferentiationRuven Wilkens, Jürgen Korffmann, Nathalie Nicolaisen, et al.
Plos One|January 1, 2016
Using Human iPSC-Derived Neurons to Model TAU AggregationAn Verheyen, Annick Diels, Joyce Dijkmans, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 12, 2012
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophreniaXavier Langlois, Anton Megens, Hilde Lavreysen, et al.
Journal of Pharmacological and Toxicological Methods|May 15, 2009
Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?Rob Towart, Joannes T M Linders, An N Hermans, et al.
Pageof 2